Displaying drugs 8776 - 8800 of 11430 in total
Dibromotyrosine
Experimental
Matched Iupac: … (2S)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic acid …
Indium cation In-111
Experimental
Matched Synonyms: … Indium cation In-111 (3+) …
Matched Iupac: … (111In)indium(3+) ion …
Matched Iupac: … (111In)indium(3+) ion …
Naquotinib
Naquotinib has been used in trials studying the treatment of Solid Tumors, Non-small Cell Lung Cancer, Non-Small-Cell Lung Cancer (NSCLC), Epidermal Growth Factor Receptor Mutations, and Epidermal Growth Factor Receptor (EGFR) Mutations, among others.
Investigational
Matched Iupac: … 6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-{[(3R)-1-(prop-2-enoyl)pyrrolidin ... -3-yl]oxy}pyrazine-2-carboxamide …
Carbon black
Produced by the incomplete combustion of hydrocarbons, carbon black is an insoluble pigment with demonstrated adverse effects on pulmonary function. Upon inhalation, carbon black has been reported to trigger an inflammatory response in the lung tissue and has been linked to carcinogenicity.[A263406, A263411, A263416]
Investigational
Matched Synonyms: … BLACK 2 ... D&C black no. 2 ... DC BLACK NO. 2 …
Proline
Proline is one of the twenty amino acids used in living organisms as the building blocks of proteins. Proline is sometimes called an imino acid, although the IUPAC definition of an imine requires a carbon-nitrogen double bond. Proline is a non-essential amino acid that is synthesized from glutamic acid. It...
Nutraceutical
Matched Synonyms: … (S)-2-Carboxypyrrolidine ... (-)-2-Pyrrolidinecarboxylic acid ... 2-Pyrrolidinecarboxylic acid …
Matched Iupac: … (2S)-pyrrolidine-2-carboxylic acid …
Matched Mixtures name: … AMINOMIX 3 SOLÜSYON, 1000 ML ... AMINOMIX 3 SOLÜSYON, 2000 ML ... AMINOMIX 3 SOLÜSYON, 15000 ML …
Matched Iupac: … (2S)-pyrrolidine-2-carboxylic acid …
Matched Mixtures name: … AMINOMIX 3 SOLÜSYON, 1000 ML ... AMINOMIX 3 SOLÜSYON, 2000 ML ... AMINOMIX 3 SOLÜSYON, 15000 ML …
Dibenzofuran-4,6-Dicarboxylic Acid
Experimental
Matched Iupac: … 8-oxatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),3,5,10,12-hexaene-6,10-dicarboxylic acid …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
ALT-P7
Investigational
Taniraleucel
Investigational
Matched Synonyms: … differentiated in the presence of cytokines including thrombopoietin, SCF, Flt3 ligand, IL-7, IL-15 and IL-2 …
Ezutromid
Ezutromid has been investigated for the treatment of Muscular Dystrophy, Duchenne.
Investigational
Matched Synonyms: … 5-(Ethylsulfonyl)-2-(naphthalen-2-yl)benzo(d)oxazole ... Benzoxazole, 5-(ethylsulfonyl)-2-(2-naphthalenyl)- …
Matched Iupac: … 5-(ethanesulfonyl)-2-(naphthalen-2-yl)-1,3-benzoxazole …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Matched Iupac: … 5-(ethanesulfonyl)-2-(naphthalen-2-yl)-1,3-benzoxazole …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Bermekimab
Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).
Investigational
SB719125
Investigational
Ropidoxuridine
Ropidoxuridine is a novel, orally available, thymidine analogue and prodrug for IUdR, which demonstrated a survival advantage in Phase II studies in anaplastic astrocytoma, a type of brain tumor.
Investigational
Matched Synonyms: … 5-iodo-2-pyrimidinone-2'-deoxyribose ... 1-(2-DEOXY-.BETA.-D-ERYTHRO-PENTOFURANOSYL)-5-IODOPYRIMIDIN-2(1H)-ONE ... 2(1H)-PYRIMIDINONE, 1-(2-DEOXY-.BETA.-D-ERYTHRO-PENTOFURANOSYL)-5-IODO- …
Matched Iupac: … 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2-dihydropyrimidin-2-one …
Matched Iupac: … 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2-dihydropyrimidin-2-one …
Lorukafusp alfa
Lorukafusp alfa is under investigation in clinical trial NCT01334515 (Biological Therapy, Sargramostim, and Isotretinoin in Treating Patients With Relapsed or Refractory Neuroblastoma).
Investigational
Eflepedocokin alfa
Eflepedocokin alfa is a recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 human interleukin 22 (IL-22) molecules linked to an immunoglobulin constant region (IgG2-Fc).[A225706, L27661] It is being developed by Evive Biotech (previously known as Generon BioMed Inc).
Investigational
Matched Description: … recombinant IL-22-Fc fusion protein manufactured in Chinese hamster ovary cells that is composed of 2 …
(R)-Mandelic acid
Experimental
Matched Synonyms: … (2R)-2-hydroxy-2-phenylacetic acid ... (R)-2-Hydroxy-2-phenylacetic acid ... D-2-phenylglycolic acid …
Matched Iupac: … (2R)-2-hydroxy-2-phenylacetic acid …
Matched Iupac: … (2R)-2-hydroxy-2-phenylacetic acid …
2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose
Experimental
Matched Name: … 2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose …
Matched Iupac: … (2R,3R,4R,5S,6R)-5-{[(2S,3R,4S,5R,6R)-3-fluoro-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl …
Matched Iupac: … (2R,3R,4R,5S,6R)-5-{[(2S,3R,4S,5R,6R)-3-fluoro-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl …
Cobaltous cation
Experimental
Matched Synonyms: … Cobalt(2+) …
Matched Iupac: … lambda2-cobalt(2+) ion …
Matched Iupac: … lambda2-cobalt(2+) ion …
Etigilimab
Etigilimab is under investigation in clinical trial NCT04761198 (A Study of Etigilimab and Nivolumab in Subjects With Locally Advanced or Metastatic Tumors.).
Investigational
Pepinemab
Pepinemab is under investigation in clinical trial NCT03769155 (VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma).
Investigational
5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE
Experimental
Matched Name: … 5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE …
Matched Iupac: … 5-cyano-N-[(2,5-dimethoxyphenyl)methyl]-6-ethoxypyridine-2-carboxamide …
Matched Iupac: … 5-cyano-N-[(2,5-dimethoxyphenyl)methyl]-6-ethoxypyridine-2-carboxamide …
Hydracrylic acid
Experimental
Matched Synonyms: … 3-Hydroxypropanoic acid ... 3-Hydroxypropionic acid …
Matched Iupac: … 3-hydroxypropanoic acid …
Matched Iupac: … 3-hydroxypropanoic acid …
SGS-742
SGS-742 has been used in trials studying the treatment of Seizures and Metabolic Disease.
Investigational
Matched Synonyms: … 3-Aminopropyl-Butyl Phosphinic Acid ... (3-Aminopropyl)(n-butyl)phosphinic acid …
Matched Iupac: … (3-aminopropyl)(butyl)phosphinic acid …
Matched Iupac: … (3-aminopropyl)(butyl)phosphinic acid …
3'-O-Acetylthymidine-5'-diphosphate
Experimental
Matched Synonyms: … 3'-O-Acetylthymidine 5'-(trihydrogen diphosphate) …
Matched Name: … 3'-O-Acetylthymidine-5'-diphosphate …
Matched Iupac: … [({[(2R,3S,5R)-3-(acetyloxy)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy …
Matched Name: … 3'-O-Acetylthymidine-5'-diphosphate …
Matched Iupac: … [({[(2R,3S,5R)-3-(acetyloxy)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)oxolan-2-yl]methoxy …
sn-glycero-3-phosphoethanolamine
Experimental
Matched Name: … sn-glycero-3-phosphoethanolamine …
Matched Iupac: … (2-aminoethoxy)[(2S)-2,3-dihydroxypropoxy]phosphinic acid …
Matched Iupac: … (2-aminoethoxy)[(2S)-2,3-dihydroxypropoxy]phosphinic acid …
DCLL-9718S
DCLL9718S is an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1). DCLL9718S is under investigation in clinical trial NCT03298516 (A Study of DCLL9718S in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) or DCLL9718S in Combination With Azacitidine in Participants With Previously Untreated AML Unsuitable for Intensive Induction Chemotherapy).
Investigational
Displaying drugs 8776 - 8800 of 11430 in total